Visual axis opacification · children younger than two years of age with bilateral congenital cataracts
It is very uncertain whether summary of findings table ‐ Pseudophakia changes visual axis opacification compared with aphakia (very low certainty).
1 finding from 1 review
Amblyopia ‐ not reported · children younger than two years of age with bilateral congenital cataracts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Glaucoma at 5 years · children younger than two years of age with bilateral congenital cataracts
It is very uncertain whether summary of findings table ‐ Pseudophakia changes glaucoma at 5 years compared with aphakia (very low certainty).
1 finding from 1 review
Retinal detachment ‐ not reported · children younger than two years of age with bilateral congenital cataracts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reoperation rate ‐ not reported · children younger than two years of age with bilateral congenital cataracts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children younger than two years of age with bilateral congenital cataracts
1 finding from 1 review
Complete remission of proteinuria · adults with FSGS
Cyclosporin may leads to higher complete remission of proteinuria compared with different comparators (low certainty).
1 finding from 1 review
Partial remission of proteinuria · adults with FSGS
Cyclosporin showed no clear difference in partial remission of proteinuria compared with different comparators (low certainty).
1 finding from 1 review
Complete or partial remission · adults with FSGS
Cyclosporin may leads to higher complete or partial remission compared with different comparators (low certainty).
1 finding from 1 review
Chronic kidney disease · adults with FSGS
Cyclosporin showed no clear difference in chronic kidney disease compared with different comparators (low certainty).
1 finding from 1 review
Kidney failure · adults with FSGS
Cyclosporin showed no clear difference in kidney failure compared with different comparators (low certainty).
1 finding from 1 review
Adverse events: hypertension · adults with FSGS
1 finding from 1 review
Adverse effects: infection · adults with FSGS
1 finding from 1 review
PE: assessed by CT arteriography ( · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in PE: assessed by CT arteriography ( compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Symptomatic DVT · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in symptomatic DVT: assessed by presence of symptoms and confirmed by a… compared with no prophylaxis (low certainty).
1 finding from 1 review
Asymptomatic DVT · adults undergoing KA
It is very uncertain whether low‐molecular‐weight heparin changes asymptomatic DVT: compared with no prophylaxis (very low certainty).
1 finding from 1 review
All‐cause mortality ( · adults undergoing KA
1 finding from 1 review
All adverse effects, including allergies at injection site, minor and major bleeding, others ( · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in all adverse effects, including allergies at injection site, minor… compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Major bleeding · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in major bleeding ( compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Minor bleeding · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in minor bleeding ( compared with no prophylaxis (moderate certainty).
1 finding from 1 review